Abstract
In the last few decades, the pharmaceutical application of marine natural products has attracted much attention from both organic and medicinal chemists. Recently, significant interest is focused on the isolation, identification, and biological activities of compounds from the Red Sea organisms and many of these compounds show promising biological activities, particularly cytotoxic and antimicrobial effects. This review covers the natural products and their biological activities isolated from the Red Sea flora and fauna in the recent past years.
Keywords: Anticancer, antimicrobials, bromophenols, cerebranoids, hyrtioerectines, lactones, latrunculins, marine natural products.
Graphical Abstract
Medicinal Chemistry
Title:Potential Therapeutic Agents from the Red Sea Organisms
Volume: 10 Issue: 6
Author(s): Mohammad Abrar Alam
Affiliation:
Keywords: Anticancer, antimicrobials, bromophenols, cerebranoids, hyrtioerectines, lactones, latrunculins, marine natural products.
Abstract: In the last few decades, the pharmaceutical application of marine natural products has attracted much attention from both organic and medicinal chemists. Recently, significant interest is focused on the isolation, identification, and biological activities of compounds from the Red Sea organisms and many of these compounds show promising biological activities, particularly cytotoxic and antimicrobial effects. This review covers the natural products and their biological activities isolated from the Red Sea flora and fauna in the recent past years.
Export Options
About this article
Cite this article as:
Alam Abrar Mohammad, Potential Therapeutic Agents from the Red Sea Organisms, Medicinal Chemistry 2014; 10 (6) . https://dx.doi.org/10.2174/1573406409666131224105602
DOI https://dx.doi.org/10.2174/1573406409666131224105602 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Angiogenesis New Targets for the Development of Anticancer Chemotherapies
Current Pharmaceutical Design Differential Splicing, Disease and Drug Targets
Infectious Disorders - Drug Targets Sphingolipids in Inflammation: Roles and Implications
Current Molecular Medicine Apis mellifera Proteomics: Where Will the Future Bee?
Current Proteomics Miracles of Herbal Phytomedicines in Treatment of Skin Disorders: Natural Healthcare Perspective
Infectious Disorders - Drug Targets Spectrometric Studies on Antioxidant Activity of Pinus Nigra Resin in Vitro and Its Total Phenolic and Flavonoid Content
Current Pharmaceutical Analysis Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Current Medicinal Chemistry - Central Nervous System Agents Polymer-Drug Nanoconjugate – An Innovative Nanomedicine: Challenges and Recent Advancements in Rational Formulation Design for Effective Delivery of Poorly Soluble Drugs
Pharmaceutical Nanotechnology Recent Developments and Applications of Derivative Spectrophotometry in Pharmaceutical Analysis
Current Pharmaceutical Analysis Vitamin, Mineral, and Drug Absorption Following Bariatric Surgery
Current Drug Metabolism Mucosal Repair and COX-2 Inhibition
Current Pharmaceutical Design Is Helicobacter pylori the Infectious Target to Prevent Gastric Cancer? An Interdisciplinary Point of View
Infectious Disorders - Drug Targets Thymic Immunosuppressive Pentapeptide (TIPP) Shown Anticancer Activity in Breast Cancer and Chronic Myeloid Leukemia Both <i>In Vitro</i> and <i>In Vivo</i>
Protein & Peptide Letters Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Heterogeneity of Cholecystokinin Receptors: A New Interest Towards the Development of CCK2 Agonists
Current Medicinal Chemistry - Central Nervous System Agents Biomarkers for Predicting the Immunomodulatory Properties of Probiotics
Recent Patents on Biomarkers Carrier Mediated Systemic Delivery of Protein and Peptide Therapeutics
Current Pharmaceutical Design Cancer Biomarker Discovery for Precision Medicine: New Progress
Current Medicinal Chemistry Bone Target Radiotracers for Palliative Therapy of Bone Metastases
Current Medicinal Chemistry Targeted Therapies in Breast Cancer: Established Drugs and Recent Developments
Current Clinical Pharmacology